Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Li, Lifeng  [Clear All Filters]
2023
Deng J, Pan T, Lv C, Cao L, Li L, Zhou X, Li G, Li H, Vicencio JM, Xu Y, et al. Exosomal transfer leads to chemoresistance through oxidative phosphorylation-mediated stemness phenotype in colorectal cancer. Theranostics. 2023;13(14):5057-5074.
Xie X, Li L, Xie L, Liu Z, Zhang G, Gao X, Peng W, Deng H, Yang Y, Yang M, et al. Stratification of non-small cell lung adenocarcinoma patients with EGFR actionable mutations based on drug-resistant stem cell genes. iScience. 2023;26(6):106584.
2022
Duan X, Yang L, Wang L, Liu Q, Zhang K, Liu S, Liu C, Gao Q, Li L, Qin G, et al. m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer. Cell Biosci. 2022;12(1):60.
2021
Liu Z, Ren Y, Meng L, Li L, Beatson R, Deng J, Zhang T, Liu J, Han X. Epigenetic Signaling of Cancer Stem Cells During Inflammation. Front Cell Dev Biol. 2021;9:772211.
Bao W, Zhang Q, Zheng H, Li L, Liu M, Cheng H, Wong T, Zhang G, Lu A, Bian Z, et al. Radix Astragali polysaccharide RAP directly protects hematopoietic stem cells from chemotherapy-induced myelosuppression by increasing FOS expression. Int J Biol Macromol. 2021.
2018
Fan Z, Xue W, Dou M, Li L, Lu J, Ma B, Deng X, Zhang M, Zhai Y, Wang S, et al. Bushenshugan Formula Attenuates the Development of Lung Cancer by Inhibiting Epithelial-Mesenchymal Transition. Cell Physiol Biochem. 2018;47(5):1977-1988.